Elevated concentration of cerebrospinal fluid tissue transglutaminase in Parkinson's disease indicating apoptosis

@article{Vermes2004ElevatedCO,
  title={Elevated concentration of cerebrospinal fluid tissue transglutaminase in Parkinson's disease indicating apoptosis},
  author={Istv{\'a}n Vermes and Ernst N. H. Jansen Steur and Gustav F. Jirikowski and Clemens Haanen},
  journal={Movement Disorders},
  year={2004},
  volume={19}
}
Tissue transglutaminase (tTG) is activated during the apoptotic cell death cascade and plays a key role in the formation of apoptotic bodies. We found significant elevation of tTG concentration in the cerebrospinal fluid (CSF) of 54 patients with Parkinson's disease (PD) compared with that measured in 34 control subjects, thus showing increased neural cell apoptosis in patients with PD. © 2004 Movement Disorder Society 
Transglutaminase activation in neurodegenerative diseases.
TLDR
The role of calcium in promoting the in vitro and in vivo activation of transglutaminases in neurodegenerative disorders is examined and the potential clinical relevance of transGLutaminase inhibitors is reviewed. Expand
Increase in endoplasmic reticulum-associated tissue transglutaminase and enzymatic activation in a cellular model of Parkinson's disease
TLDR
The data provide strong evidence for a, so far unrecognized, localization of t TG at the ER, at least in catecholaminergic neurons, and suggests that in PD activation of tTG may have a direct impact on ER function, in particular via post-translational modification of ER membrane proteins. Expand
Transglutaminase 2 in neurodegenerative disorders.
TLDR
There is data to suggest that TG2 may play a role in neurodegenerative processes by stabilizing toxic oligomers of the disease-relevant proteins, although further studies are needed to validate these initial in vitro findings. Expand
Endoplasmic reticulum-stress and protein aggregation in Parkinson's disease: elucidating the contribution of tissue transglutaminase
Transamidation of α-synuclein by the Ca2+-dependent enzyme tissue transglutaminase (tTG, EC 2.3.2.13) is implicated in Parkinson’s disease (PD). tTG may therefore offer a novel therapeutic target toExpand
Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease
TLDR
This review article summarizes the studies reported on CSF levels of many potential biomarkers of Parkinson's disease and finds the most consistent findings are: the possible role of CSF urate on the progression of the disease and the possible relations ofCSF total tau and phosphotau protein with the progress of PD. Expand
Critical role of transglutaminase and other stress proteins during neurodegenerative processes
TLDR
Observations seem to suggest that transglutaminase activity could be involved in the stabilization of intracellular protein aggregates by interfering with proteasomal degradation of misfolded proteins. Expand
Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications.
TLDR
The biochemistry of TG2, its various physiologic functions and current understanding about its role in degenerative diseases of the brain are discussed and the different approaches to designing TG2 inhibitors that could be developed as potential disease-modifying therapies are described. Expand
Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of α-synuclein in a cellular model of Parkinson's disease
TLDR
It is concluded that α-synuclein is a cellular substrate for tTG under conditions mimicking PD and blockade of tTG activity counteracts α- synuclein transamidation and aggregation in vitro and in living cells. Expand
Transglutaminases and neurodegeneration
TLDR
The following review summarizes the involvement of TGs in neurodegenerative diseases and discusses the possible use of selective inhibitors as therapeutic agents in these diseases. Expand
Distribution of Transglutaminase 6 in the Central Nervous System of Adult Mice
TLDR
A comprehensive immunohistochemical examination of the expression profile of TG6 in adult mouse brain found numerous TG6‐positive neurons were found in the key brain regions involved in regulating locomotion activity, including the globus pallidus, subthalamic nucleus, substantia nigra, cerebellum, some precerebellar nuclei and spinal motor neurons. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
Cerebrospinal fluid tissue transglutaminase in vascular dementia
TLDR
TTG, as a specific marker for apoptosis, may be a powerful biochemical marker of the acute degenerating process in vivo and may be useful in discrimination between vascular dementia (VaD) and Alzheimer's disease (AD). Expand
Cerebrospinal Fluid Tissue Transglutaminase as a Biochemical Marker for Alzheimer's Disease
TLDR
The results suggest that tTG may be a powerful biochemical marker of the acute degenerating process in vivo and serve as completion of CSF analysis in the diagnosis of dementing disorders and May be a simple way of assessing the efficacy of possible new antiapoptotic drugs. Expand
Decreased concentration of Annexin V in Parkinsonian cerebrospinal fluid: Speculation on the underlying cause
TLDR
The Annexin V concentration in CSF of patients with PD was significantly lower compared with control subjects, and annexin V concentrations of the CSF did not correlate with dementia, duration of symptoms, age, sex, or treatment of PD. Expand
Tissue transglutaminase-induced aggregation of α-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies
TLDR
Findings suggest that tTGase activity leads to α-synuclein aggregation to form Lewy bodies and perhaps contributes to neurodegeneration. Expand
Transglutaminase‐mediated crosslinking of neural proteins in Alzheimer's disease and other primary dementias
TLDR
A series of studies from the laboratory showed that elevated crosslink concentrations in cerebrospinal fluid are characteristic of AD as well as other related dementias associated with the formation of intraneural inclusions, and may reveal a common pathogenic mechanism in various primary neurodegenerative diseases. Expand
Apoptosis and caspases in neurodegenerative diseases.
TLDR
Pharmacologic interference with the induction or completion of apoptosis holds promise for the treatment of neurodegenerative diseases, and clinical trials with one such agent are already under way. Expand
Apoptosis in the nervous system
TLDR
The principal molecular components of the apoptosis programme in neurons include Apaf-1 (apoptotic protease-activating factor 1) and proteins of the Bcl-2 and caspase families, which regulate neuronal apoptosis through the action of critical protein kinase cascades. Expand
Tissue transglutaminase mRNA expression in apoptotic cell death
TLDR
The TaqMan RT-PCR of t.TG proved to be reliable, reproducible, and specific for apoptotic cell death, leading to the conclusion that t. Expand
Transglutaminase 2: an enigmatic enzyme with diverse functions.
TLDR
An important role for the enzyme in the pathogenesis of coeliac disease, fibrosis and neurodegenerative disorders has also been demonstrated, making TG2 an important therapeutic target. Expand
Flow cytometry of apoptotic cell death.
TLDR
This review outlines the main stages of the apoptotic cascade together with current FCM methods and states that all FCM apoptosis assays described have a solid experimental basis and have been used successfully in basic research on molecular and biochemical mechanisms of apoptosis. Expand
...
1
2
3
...